Zogenix reported $76.48M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 146.91M 12.02M
Acura Pharmaceuticals ACUR:US 913K 123K
Adamas Pharmaceuticals ADMS:US 31.53M 405K
Aerie Pharmaceuticals AERI:US $ 61.69M 3M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Arena Pharmaceuticals ARNA:US $ 194.48M 50.09M
AstraZeneca AZN:LN 11.54B 4.45B
Becton, Dickinson and BDX:US $ 4640M 378M
Biocryst Pharmaceuticals BCRX:US $ 85.58M 6.04M
Biogen BIIB:US $ 1984.9M 304.4M
Cardinal Health CAH:US 43.56B 1.13B
Esperion Therapeutics ESPR:US $ 70.15M 3.04M
Flexion Therapeutics FLXN:US $ 44.98M 73K
GlaxoSmithKline GSK:LN 7.14B 722M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Heron Therapeutics HRTX:US $ 74.94M 7.97M
Intra Cellular Therapies ITCI:US $ 99.53M 10.34M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Marinus Pharmaceuticals MRNS:US $ 29.28M 3.89M
Merk MRK:US $ 8328M 1460M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Pfizer PFE:US $ 16447M 3384M
Revance Therapeutics RVNC:US $ 92.47M 3.33M
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
Teva Pharmaceutical TEVA:IT 3.26B 64M
Zogenix ZGNX:US $ 76.48M 2.26M